Score
1
2000
pubmed
[Ultrastructural changes in the pancreas of rats with acute pancreatitis after semax administration].
Ivanov. Iu V IuV
Key Findings
- A single intraductal dose of semax (0.1 mg/kg) reduced necrosis of pancreatic acinar cells in rats with acute pancreatitis.
- Semax limited purulent inflammation by promoting sclerosis and atrophy of damaged lobules.
- Overall, larger areas of the pancreas remained intact compared to untreated rats.
Practical Outcomes
- The results are limited to an animal model of a specific disease and involve direct injection into the pancreas, which is not feasible for self‑administration. While the data suggest semax may have protective effects on pancreatic tissue, there is no actionable protocol for human use in longevity or performance contexts without further clinical research.
Summary
In a rat study, giving a single dose of the peptide semax directly into the pancreas helped protect the organ during severe inflammation (acute pancreatitis). It reduced tissue death and limited harmful infection, keeping more of the pancreas healthy.
Abstract
Semax favorably affects ultrastructural changes in the pancreas of rats with acute pancreatitis (AP): a single introduction of semax (0.1 mg/kg) into the pancreatic duct of rats with AP model prevents increased necrosis of the acinar tissues and inhibits purulent inflammation of the necrotised lobules by inducing their sclerosis and atrophy, thus retaining large areas of the pancreas intact.
Study Information
Provider
pubmed
Year
2000